Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
New Book Born to Try – Life’s Stepping Stones Offers Powerful Lessons in Resilience and Growth
Via GlobePRwire
Exposures COVID-19
David W. Smithe’s Born to Try – Life’s Stepping Stones Inspires Readers to Turn Challenges into Triumphs
Via GlobePRwire
Exposures COVID-19
Daniel Yomtobian Shows That the Pandemic Disruptions Created Brand-Building Opportunities
Via Press Release Distribution Service
Topics Economy
Exposures COVID-19 Economy
Tickers IBM
Yafay Life Inc. Exclusively Introduces Revolutionary Homeopathic Spike Protein Detox™
Via AB Newswire
Exposures COVID-19
Final Deadline: Small Businesses Must Claim ERTC Credit Before April 15, 2025
Via Press Release Distribution Service
Exposures COVID-19
Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And 2026
Via NewMediaWire
Exposures COVID-19
Tickers SNGX
As Covid Drug Cash Dwindles, Vigonvita Targets New Remedies
Via Benzinga
Exposures COVID-19
Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And 2026
Via TheNewswire.com
Exposures COVID-19
Tickers SNGX
1 Healthcare Stock to Hold Forever and 2 to Ignore
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Tickers COO COR FTRE
2 Healthcare Stocks with Big Upside and 1 to Skip
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Tickers MRK REGN ZTS
Author Dora Przybylek Releases Inspiring New Children’s Book, Luisita and COVID-19, Now Available on Amazon
Via AB Newswire
Exposures COVID-19
Tickers AMZN
Boise Cascade (NYSE:BCC) Misses Q4 Revenue Estimates
Via StockStory
Topics Economy
Exposures COVID-19 Supply Chain
Tickers BCC
Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates
Via StockStory
Exposures COVID-19
Tickers RGEN
Carvana (NYSE:CVNA) Reports Bullish Q4 But Stock Drops 10.8%
Via StockStory
Exposures COVID-19
Tickers ASX:TWR CVNA
Creative Biolabs Pioneers Vaccine Research: Cutting-Edge Tech and One-Stop Approach
Via Get News
Exposures COVID-19
BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Reports Financials, Advances NV-387 Antiviral Trials
Via Investor Brand Network
Topics Intellectual Property Regulatory Compliance
Exposures COVID-19 Intellectual Property Legal
Tickers NNVC
Superior Business Lending LLC Advises on $35M SBA Loans in 2024
Via PRUnderground
Exposures COVID-19
Massimo Group (NASDAQ: MAMO) Leads the Charge: Reshoring Manufacturing Back to the USA
Via Investor Brand Network
Topics Government World Trade
Exposures COVID-19 Political Tariff
Tickers MAMO
Moderna: A Generational Opportunity for Investors in 2025
Via MarketBeat
Exposures COVID-19 Product Safety
Tickers MRNA
Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges
Via Benzinga
Exposures COVID-19
Tickers MRNA
O2Xpress Revolutionizes Home Healthcare with the Launch of Its Advanced Home Oxygen Concentrators for Improved Respiratory Health
Via AB Newswire
Exposures COVID-19
AMC Stock Surges on Bitcoin News—Meme Stocks Making a Comeback?
Via MarketBeat
Exposures COVID-19
Tickers AMC GME MSTR
How Coast Family Home Care’s Caregivers Are Addressing Social Isolation Among Seniors
Via AB Newswire
Exposures COVID-19
“The False God’s Lullaby”: An Exploration into The Existential Depths of Human Existence
Via Get News
Exposures COVID-19
2025 Self-Employed Tax Credit Qualification Check: New Advance Funding Announced
Via Press Release Distribution Service
Exposures COVID-19
1 Healthcare Stock Primed for Growth and 2 to Avoid
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Tickers CI GDRX STE
1 Healthcare Stock Primed for Growth and 2 to Snub
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Tickers CI GDRX STE
Moderna's Q4 Loss Wider Than Expected
Via The Motley Fool
Exposures COVID-19
Tickers MRNA
Moderna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides
Via Benzinga
Exposures COVID-19
Tickers MRNA
Moderna’s (NASDAQ:MRNA) Q4 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations Significantly
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Tickers MRNA
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.